AUDREY RICE: Open Payments
NPI 1326482191 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 14 payments from 8 companies in 2025. Trend: 2023 $660 · 2024 $399 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $167 |
| E.R. Squibb & Sons, L.L.C. | 3 | $139 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, COBENFY, Auvelity, HETLIOZ, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR, LYBALVI.
Industry payments across NC — which companies pay providers there.
